From: Becker's Supply Chain Report <editorial@beckershealthcare.com>
Subject: Medtronic to resolve device probes for $51M | Gunman dies, injures 2 at U of Kansas Medical Center | CVS to offer clients 100% of drug rebates | Takeda shareholders approve $58B Shire deal
Preheader:
Reply: editorial@beckershealthcare.com
View our profile on LinkedIn Follow us on Twitter Like us on Facebook Find us on Google+ View our videos on YouTube


December 5, 2018
TODAY'S TOP STORIES
1. Medtronic to resolve medical device probes for $51M: 5 things to know 
 
2. CVS' new PBM strategy: Offering clients 100% of drug rebates  Full story

3. Gunman fatally shoots himself, injures at least 2 at U of Kansas Medical Center  Full story

4. Learn how a diverse portfolio of wound care products can help hospitals balance economic needs with clinical priorities during this upcoming webinar.

5. Takeda wins shareholder approval for $58B takeover of Shire

6. Leapfrog Group announces 2018 Top Hospitals  Full story
 
7. Ergotron's documentation carts power life-changing care with safe battery technology. Most critically, they enable caregivers to focus on what's most important: patients.  Learn more

8. Judge calls for another hearing on CVS-Aetna deal: 3 things to know  Full story
 
9. Bristol-Myers Squibb must answer lawsuit claiming it knowingly underpaid Medicaid  Full story
 
10. Trump administration issues plan to promote healthcare competition: 7 notes  Full story
  
11. Keeping the doors open and delivering care as fires engulf local communities. Learn more

12. GAO: FDA's orphan drug program is flawed: 6 things to know 


Channels
Contact Us

Editorial Contact: 
Molly Gamble 
Editor-in-Chief
(800) 417-2035
Sales, Marketing & Events:
Jessica Cole
President and CEO
 
Becker's Hospital Review
A Becker's Healthcare Publication
  www.BeckersHospitalReview.com
editorial@beckershealthcare.com
35 E. Wacker Drive, Suite 1782 | Chicago, IL 60601
Becker's Healthcare, 35 E. Wacker, Suite 1782, Chicago, IL 60601
Sent by editorial@beckershealthcare.com in collaboration with
Constant Contact